Joué-lés-Tours, France
Joué-lés-Tours, France

Time filter

Source Type

Brunault P.,Equipe de liaison et de soins en addictologie | Brunault P.,University of Tours | Gaillard P.,University of Tours | Gaillard P.,French Institute of Health and Medical Research | And 10 more authors.
Encephale | Year: 2016

Objective: The Binge Eating Scale is a widely used scale to assess binge eating disorder in obese patients. Until now, this scale has not been validated on a French population, and no psychometrically sound tool assesses binge eating disorder in the French. This study aimed to test the psychometric properties of a French version of the Binge Eating Scale by establishing its factor structure, internal consistency, and construct validity in both a non-clinical population and a clinical population (obese patients who are candidates for bariatric surgery). Methods: A total of 553 non-clinical subjects and 63 morbidly obese patients who were candidates for bariatric surgery were assessed with the BES and the Bulimic Investigatory Test, Edinburgh or BITE (which assesses both binge eating behaviours and use of inappropriate compensatory behaviours). We tested the factor structure of the instrument, its internal consistency, its construct validity with measures of binge eating, and its construct validity with measures of inappropriate compensatory behaviours to avoid weight gain. In 47 out of the 63 obese patients, we assessed binge eating disorder (SCID). Results: In the non-clinical population, the BES had a one-factor structure (which accounted for 61% of the variance), excellent internal consistency (α = 0.93), and high construct validity with measures of binge eating. In this population, construct validity with measures of inappropriate compensatory behaviours was confirmed in overweight and obese subjects (P = 0.42), but not in underweight and optimal weight subjects (P <. 0.001). In obese patients candidates for bariatric surgery, we demonstrated that the BES had a one-factor structure (which accounted for 46% of the variance), had high internal consistency (α = 0.88) and high construct validity with measures of binge eating and good construct validity with measures of inappropriate compensatory behaviours to avoid weight gain. In the subpopulation of 47 obese patients, sensitivity, specificity, positive predictive value and negative predictive value were respectively 75%, 88.4%, 37.5% and 97.4% (BES threshold = 18). Discussion: In this study, we validated a psychometrically sound French version of the Binge Eating Scale, both in a non-clinical and a clinical sample. The psychometric properties of the French version of the BES are comparable to its original version with a one-factor structure. The BES is a useful tool to assess binge eating disorder in obese patients (e.g., bariatric surgery candidates), but might not differentiate between binge eating disorder and bulimia nervosa in underweight and optimal weight subjects. © 2016 L'Encéphale, Paris.


PubMed | University of Tours, Service de medecine interne nutrition, French Institute of Health and Medical Research, University of Paris Descartes and Service de pedopsychiatrie
Type: Journal Article | Journal: L'Encephale | Year: 2016

The Binge Eating Scale is a widely used scale to assess binge eating disorder in obese patients. Until now, this scale has not been validated on a French population, and no psychometrically sound tool assesses binge eating disorder in the French. This study aimed to test the psychometric properties of a French version of the Binge Eating Scale by establishing its factor structure, internal consistency, and construct validity in both a non-clinical population and a clinical population (obese patients who are candidates for bariatric surgery).A total of 553 non-clinical subjects and 63 morbidly obese patients who were candidates for bariatric surgery were assessed with the BES and the Bulimic Investigatory Test, Edinburgh or BITE (which assesses both binge eating behaviours and use of inappropriate compensatory behaviours). We tested the factor structure of the instrument, its internal consistency, its construct validity with measures of binge eating, and its construct validity with measures of inappropriate compensatory behaviours to avoid weight gain. In 47 out of the 63 obese patients, we assessed binge eating disorder (SCID).In the non-clinical population, the BES had a one-factor structure (which accounted for 61% of the variance), excellent internal consistency (=0.93), and high construct validity with measures of binge eating. In this population, construct validity with measures of inappropriate compensatory behaviours was confirmed in overweight and obese subjects (P=0.42), but not in underweight and optimal weight subjects (P<0.001). In obese patients candidates for bariatric surgery, we demonstrated that the BES had a one-factor structure (which accounted for 46% of the variance), had high internal consistency (=0.88) and high construct validity with measures of binge eating and good construct validity with measures of inappropriate compensatory behaviours to avoid weight gain. In the subpopulation of 47 obese patients, sensitivity, specificity, positive predictive value and negative predictive value were respectively 75%, 88.4%, 37.5% and 97.4% (BES threshold=18).In this study, we validated a psychometrically sound French version of the Binge Eating Scale, both in a non-clinical and a clinical sample. The psychometric properties of the French version of the BES are comparable to its original version with a one-factor structure. The BES is a useful tool to assess binge eating disorder in obese patients (e.g., bariatric surgery candidates), but might not differentiate between binge eating disorder and bulimia nervosa in underweight and optimal weight subjects.


Brunault P.,Equipe de Liaison et de Soins en Addictologie | Brunault P.,University of Tours | Frammery J.,Equipe de Liaison et de Soins en Addictologie | Frammery J.,University of Tours | And 9 more authors.
Quality of Life Research | Year: 2014

Purpose: Although obesity surgery provides significant postoperative improvement in quality of life (QoL), it is still unclear which factors might predict improvement in QoL after surgery. We aimed to determine which factors might predict changes in physical, psychosocial, sexual QoL, and comfort with food 12 months after surgery, by putting to the test a QoL model based on Wilson and Cleary’s model. Methods: We included 126 obese patients (48.4 % had gastric banding, 34.1 % had sleeve gastrectomy, and 17.5 % had gastric bypass). At baseline, we assessed QoL (Quality of Life, Obesity and Dietetics rating scale), BMI, depression (Beck Depression Inventory), and binge eating (Bulimic Investigatory Test, Edinburgh). At 12 months, we assessed QoL and BMI. To determine the predictors for changes in each QoL dimension after surgery, we used linear mixed models adjusted for preoperative age, BMI, time, type of surgery, preoperative binge eating severity, and preoperative depression severity. Results: After 12 months, we found significant improvement in physical, psychosocial, sexual QoL, but not in comfort with food. Increased weight loss was associated with better improvement in physical and psychosocial QoL. Higher preoperative depression severity predicted poorer improvement in physical, psychosocial, and sexual QoL. Higher preoperative binge eating severity predicted poorer improvement in psychosocial, sexual QoL, and comfort with food. Conclusions: In addition to weight loss, preoperative levels of binge eating and depression should be considered as important predictors for QoL changes after bariatric surgery. Screening and treatment for preoperative depression and binge eating might improve QoL after bariatric surgery. © 2014, Springer International Publishing Switzerland.


Zidani H.,Service de medecine interne nutrition | Foughali M.,Center exploration vasculaire | Laroche J.-P.,Montpellier University Hospital Center
Journal des Maladies Vasculaires | Year: 2010

Mondor's disease is a rare cause of superficial thrombophlebitis, which is very exceptionally observed in the penis. Usually a benign condition, careful etiological search is needed to avoid missing exceptional causes. Mondor's disease is generally treated with non-steroidal anti-inflammatory drugs or low-molecular-weight heparin and resolves without sequelae. Mondor's disease and superficial venous thrombosis of the penis may or may not be a unique clinical entity. A favorable outcome with no precise etiology would favor penile Mondor's disease. © 2010 Elsevier Masson SAS.


Brunault P.,University of Tours | Jacobi D.,Service de Medecine Interne Nutrition | Jacobi D.,University of Tours | Leger J.,French Institute of Health and Medical Research | And 6 more authors.
Obesity Surgery | Year: 2011

Background: Although laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) are coexisting first-choice restrictive procedures for bariatric surgery candidates, it is possible, given their different modes of action, that these procedures have different effects on quality of life (QOL). We hypothesized that improvement of QOL and comfort with food could be better with LSG compared to LAGB. Methods: This cohort study included 131 obese patients who had either LAGB (n∈=∈102) or LSG (n∈=∈29). Patients were assessed during preoperative and at 6- and 12-month postoperative visits. Five QOL dimensions were assessed using the 'Quality of Life, Obesity and Dietetics' rating scale: physical impact, psycho-social impact, impact on sex life, comfort with food and diet experience. We compared QOL evolution between LAGB and LSG using linear mixed models adjusted for gender and body mass index at each visit. Results: Excess weight loss was 28.4∈±∈14.7% and 34.8∈±∈18.4% for LAGB and 35.7∈±∈14.3% and 43.8∈±∈17.8% for LSG at 6 and 12 months postoperatively, respectively. Both LAGB and LSG provided significant improvement in the physical, psycho-social, sexual and diet experience dimensions of QOL. LSG was associated with better improvement than LAGB in short-term (6-month) comfort with food. Conclusions: Our results add further evidence to the benefit of LSG and LAGB in obesity management. Within the first year of follow-up, there is no lasting difference in the comfort with food dimension between LSG and LABG. © 2011 Springer Science + Business Media, LLC.


Jacobi D.,Service de medecine interne nutrition | Jacobi D.,French Institute of Health and Medical Research | Maillot F.,Service de medecine interne nutrition | Maillot F.,French Institute of Health and Medical Research | And 2 more authors.
Obesite | Year: 2010

Numerous environmental factors are involved in body weight regulation, one of these being dietary calcium. This article reviews the mechanisms by which dietary calcium could favour body weight reduction and fat loss. High dietary calcium intake moderately increases faecal fat excretion through calcium soap formation. Through its effects on vitamin D and parathyroid hormone status, dietary calcium decreases intra cellular calcium in adipocytes. This, in turn, decreases the activity and expression of the fatty acid synthetase, stimulates lipolysis and increases the expression of UCP2 in vitro, but the results on body weight regulation and fat mass in vivo are not convincing. Whether dietary calcium intake influences appetite control and food intake remains to be demonstrated. The role of additional dairyderived compounds is also reiterated. © Springer Paris 2009.

Loading Service de Medecine Interne Nutrition collaborators
Loading Service de Medecine Interne Nutrition collaborators